Paradigm Genetics

Dec 07, 05
	NEW STORY
16:30 ET	ISS Recommends That Icoria, Inc. Shareholders Vote in Favor of Proposed Merger With Clinical Data, Inc.
Nov 14, 05
16:25 ET	Icoria Announces 2005 Third Quarter Financial Results
Nov 02, 05
08:30 ET	Icoria to Announce 2005 Third Quarter Financial Results on November 14
Oct 20, 05
08:34 ET	Icoria Receives Second Phase II SBIR Contract for Liver Injury Biomarkers
Sep 29, 05
08:31 ET	Icoria Receives Notice of Allowance on Tissue Analysis Patent
Sep 20, 05
08:35 ET	Clinical Data, Inc. to Acquire Icoria, Inc.
Sep 08, 05
08:31 ET	Icoria's Paradigm Array Labs Unit Secures Three Contracts for up to $1.1 Million in Revenue
Aug 29, 05
10:43 ET	Icoria Awarded $1.2 Million Liver Injury Contract From NIEHS
Aug 23, 05
13:30 ET	Icoria to Conduct Biomarker Study for Isis Pharmaceuticals
Aug 15, 05
16:40 ET	Icoria Announces 2005 Second Quarter Financial Results
Aug 08, 05
08:32 ET	Icoria to Announce 2005 Second Quarter Financial Results on August 15
Jul 22, 05
08:30 ET	Icoria Adds Anna Mae Diehl, M.D., Leading Liver Disease Expert, to Its Scientific Advisory Board
Jun 23, 05
08:30 ET	Icoria Receives NASDAQ Delisting Notice
May 23, 05
08:31 ET	Icoria to Present at Fourth Annual Needham & Company Biotechnology Conference
May 16, 05
16:15 ET	Icoria Announces First Quarter 2005 Results
May 12, 05
08:30 ET	Icoria to Announce 2005 First Quarter Financial Results on May 16
May 11, 05
08:33 ET	Icoria Names Doug Morton Interim CEO, Makes Management Changes to Focus on Healthcare
Apr 27, 05
08:02 ET	Icoria to Profile Liver Progenitor Stem Cells for Vesta Therapeutics
Apr 19, 05
09:30 ET	Icoria to Identify Biomarkers in Liver Cells for Predictive Toxicology in Collaboration with ADMET Technologies
Mar 30, 05
08:03 ET	Icoria Announces Board and Management Changes
Mar 24, 05
08:32 ET	Icoria Reports Q4 and Year-End Results
08:31 ET	Icoria to Focus on Healthcare Biotechnology, Expects Benefit of $15 Million From Agriculture Asset Divestiture
08:30 ET	Monsanto Company to Acquire Selected Agricultural Genomics Assets from Icoria
Feb 28, 05
08:01 ET	Icoria Signs Licensing Agreement with Syngenta
Feb 25, 05
08:06 ET	Icoria to Reschedule Results Announcement
Feb 17, 05
08:01 ET	Icoria to Present Biomarker, Systems Biology and Liver Toxicity Data at Annual Society of Toxicology Meeting
Feb 14, 05
08:01 ET	Icoria to Present at BIO CEO & Investor Conference 2005
Feb 09, 05
08:00 ET	Icoria Receives Seventh U.S. Patent on Novel Fungicide Target
Feb 04, 05
08:00 ET	Icoria to Announce 2004 Fourth Quarter and Full Year Results on March 1
Feb 01, 05
08:02 ET	Icoria Signs Deal to Screen Chemicals from DuPont Crop Protection to Identify New Agricultural Products
Jan 27, 05
08:02 ET	Icoria to Study Chemical Warfare Agent Detection With U.S. Army Edgewood Chemical Biological Center
Dec 22, 04
08:02 ET	Icoria Granted 180 Day Minimum Bid Price Extension by Nasdaq
Dec 20, 04
11:00 ET	Icoria Comments on Recent Share Volume
Dec 17, 04
08:36 ET	Icoria Receives Notice of Allowance on Metabolomics Patent
Dec 15, 04
16:15 ET	Icoria Transfers Listing to Nasdaq SmallCap Market
Dec 01, 04
08:30 ET	New Patent Enhances Icoria's Tissue Analysis Product Offering
Nov 08, 04
06:01 ET	Icoria Announces 2004 Third Quarter Financial Results
Oct 26, 04
08:11 ET	Icoria Expands Fungicide Patent Portfolio
Oct 21, 04
08:04 ET	Icoria Secures $5 Million Financing
Oct 15, 04
09:30 ET	Icoria and Rosetta Genomics Sign Exclusive Agreement to Provide microRNA Detection and Analysis Services Utilizing Proprietary MirChip(TM) Technology
Oct 07, 04
11:21 ET	Icoria Expands Partnering With Agilent Technologies to Include $11.7 Million ATP Grant for Informatics
Sep 20, 04
12:56 ET	Icoria Now Offers GLP Compliant Gene Expression Profiling Services Through Its Paradigm Array Labs Services Unit
Aug 17, 04
16:00 ET	Paradigm Genetics, Inc. Changes Corporate Identity to Icoria, Inc.
Aug 11, 04
18:01 ET	Paradigm Genetics Enters Collaboration With Arcturus Biosciences to Provide Microgenomics & Laser Capture Microdissection Technology Services
Aug 02, 04
09:30 ET	Paradigm Genetics Announces 2004 Second Quarter Financial Results
Jun 28, 04
08:31 ET	Paradigm Genetics and National Institute of Environmental Health Sciences Expand Liver Toxicity Collaboration
Jun 23, 04
15:15 ET	Paradigm Genetics Awarded Fast Track NIH Funding for Biomarker Research in Alcohol Induced Liver and Brain Injury
Jun 22, 04
08:30 ET	Paradigm Genetics and Experimental Pathology Laboratories Announce Collaboration to Further Develop Paradigm Genetics Automated Pathology Software
Jun 21, 04
13:47 ET	Paradigm Genetics Reports Improved Detection of Liver Disease Using Automated Pathology Software
08:32 ET	Paradigm Genetics Receives Fast-Track Contract From National Institutes of Health for Liver Toxicity Research
Jun 16, 04
08:38 ET	Paradigm Genetics to Present at Needham & Company Third Annual Biotech Conference
Jun 10, 04
09:59 ET	Paradigm Genetics to Add Pharmaceutical Executive to Its Board of Directors
May 25, 04
11:56 ET	Paradigm Genetics Adds Two More Patents to its Fungicide Patent Portfolio
May 06, 04
08:35 ET	Paradigm Genetics and National Institute of Environmental Health Sciences Expand Technology Focus of Contract
Apr 26, 04
18:10 ET	Paradigm Genetics Announces 2004 First Quarter Financial Results
Apr 22, 04
12:35 ET	Paradigm Receives Second U.S. Patent for Fungicide Target Pathway
Mar 22, 04
08:34 ET	Paradigm Genetics to Present Biomarker Data at the Society of Toxicology Annual Meeting
Mar 16, 04
09:56 ET	Paradigm Genetics Appoints Former Pfizer Executive to its Board of Directors
Mar 11, 04
18:18 ET	Paradigm Genetics Completes Acquisition of TissueInformatics.Inc, Positioning Paradigm Genetics as a Systems Biology Leader
Feb 24, 04
10:03 ET	Paradigm Genetics to Participate in Biomarkers Focus Session at BIO CEO & Investor Conference 2004
Feb 19, 04
18:00 ET	Paradigm Genetics Announces 2003 Fourth Quarter and Year End Financial Results
16:04 ET	Webcast Alert: Paradigm Genetics Inc. Webcast
Jan 29, 04
17:00 ET	Paradigm Genetics to Acquire TissueInformatics Creating a Unique Systems Biology Platform for Life Sciences Discovery
Dec 19, 03
13:27 ET	Paradigm Genetics Signs Three-Year, Multi-Million Dollar Crop Trait Collaboration With Pioneer Hi-Bred International, Inc.
Nov 20, 03
08:35 ET	Paradigm Genetics Signs Fungicide Evaluation Agreement With Bayer CropScience
Nov 17, 03
08:32 ET	Paradigm Genetics Signs Two-Year Extension With Bayer CropScience
Nov 12, 03
18:02 ET	Paradigm Genetics Announces 2003 Third Quarter Financial Results
Nov 07, 03
07:45 ET	Webcast Alert: Paradigm Genetics Announces Third Quarter 2003 Earnings Results Conference Call on the Web
Oct 29, 03
16:12 ET	Webcast Alert: Paradigm Genetics Announces Third Quarter 2003 Earnings Results Conference Call on the Web
Oct 28, 03
08:31 ET	Paradigm Genetics First Company to Qualify for Agilent Technologies' Certified Microarray Service Provider Program
Oct 24, 03
11:00 ET	Paradigm Genetics Executive John Hamer to Join Burrill & Company
Oct 23, 03
11:30 ET	Paradigm Genetics Receives U.S. Patent for Fungicide Target; Target Part of Fungal Pathway for Lysine Production
Oct 20, 03
08:05 ET	Paradigm Genetics and Affymetrix Sign Services And Biotech Access(TM) Agreements
Sep 30, 03
11:02 ET	Paradigm Genetics and University of North Carolina Enter Collaboration To Identify Biomarkers of Choline Deficiency
Aug 14, 03
09:48 ET	Paradigm Genetics Announces New Profiling Method for Verifying Gene Function And Determining Chemical Mode of Action in Fungi
Aug 06, 03
17:49 ET	Paradigm Genetics Announces 2003 Second Quarter Financial Results
Jul 31, 03
08:30 ET	Webcast Alert: Paradigm Genetics, Inc. Announces Q2 2003 Financial Release Webcast
08:30 ET	Webcast Alert: Paradigm Genetics, Inc. Announces Q2 2003 Financial Release Webcast
Jul 10, 03
07:55 ET	Paradigm Genetics Secures $7.5 Million Debt Financing with Silicon Valley Bank
Jun 23, 03
09:02 ET	Paradigm Genetics Enters Biomarker Research Collaboration with the University Of North Carolina at Chapel Hill and the National Institute of Environmental Health Sciences
Jun 06, 03
12:30 ET	Paradigm Genetics Regains Nasdaq Compliance and Avoids Delisting
Jun 02, 03
11:10 ET	Paradigm Genetics Continues Expansion of Its Human Health Unit Through Additional Key Appointments
May 27, 03
08:54 ET	Genes Analyzed by Paradigm Genetics Enter Crop Testing Pipeline at Monsanto
May 15, 03
14:16 ET	Paradigm Granted U.S. Patent for its TAG-KO(R) Technology
Apr 30, 03
17:15 ET	Paradigm Genetics Announces 2003 First Quarter Financial Results
Apr 24, 03
09:46 ET	Paradigm Signs $8.4 Million Addition to $23.8 Million Contract With NIEHS
Apr 23, 03
07:30 ET	You Are Cordially Invited to the Paradigm Genetics First Quarter 2003 Financial Results Conference Call Webcast
Apr 15, 03
08:01 ET	Paradigm Strengthens Human Health Unit Through Key Appointments In Medical Informatics and Computational Biology
Apr 09, 03
08:02 ET	Paradigm Genetics Receives Extension From Nasdaq; Company to Report 2003 First Quarter Results by Conference Call May 1, 2003
Mar 26, 03
09:15 ET	Paradigm Genetics Launches Gene Expression Microarray Services Business; Signs Co-Marketing Agreement with Agilent Technologies
Mar 19, 03
10:12 ET	Paradigm Genetics and TissueInformatics to Partner in the Discovery Of Biomarkers for Chronic Liver Disease
Mar 06, 03
09:30 ET	Paradigm Genetics and Its Collaborators Announce the Discovery of the Role Of Heterotrimeric G-Protein Signaling in Plant Cell Proliferation and Its Association With Key Agronomic Traits
Feb 19, 03
18:48 ET	Paradigm Genetics Announces 2002 Fourth Quarter and Year End Financial Results
Jan 29, 03
08:05 ET	Paradigm Genetics Receives Nasdaq Notice of Delisting; Company to Appeal Notice; Stock to Continue Trading on Nasdaq NM
Jan 10, 03
07:00 ET	DNA LandMarks to Acquire Plant Genotyping Business From Paradigm Genetics
Nov 06, 02
17:45 ET	Paradigm Genetics Announces Third Quarter 2002 Financial Results
Nov 05, 02
17:17 ET	Paradigm Genetics Announces Key Executive Hires; Executive Management Team Now Complete
Oct 02, 02
09:23 ET	Paradigm Genetics to Host Webcast Outlining Revised Corporate Strategy
Oct 01, 02
08:07 ET	Paradigm Genetics Secures $23.8 Million Toxicogenomics Contract
Aug 12, 02
09:30 ET	Paradigm Genetics Announces Executive Management Changes
07:00 ET	Paradigm Genetics Announces Second Quarter 2002 Financial Results
Jul 18, 02
07:10 ET	Paradigm Genetics Appoints Chief Executive Officer
Jun 11, 02
01:30 ET	Paradigm Genetics, LION bioscience Win $11.7 Million ATP Grant
May 16, 02
08:00 ET	John Ryals to Leave Paradigm Genetics' Board of Directors
May 01, 02
17:00 ET	Paradigm Genetics Announces First Quarter 2002 Financial Results
Apr 16, 02
12:00 ET	Paradigm Genetics Completes Internal Restructuring; New Organization Will Better Position Company to Increase Shareholder Value
Apr 14, 02
07:46 ET	Webcast Alert: Paradigm Genetics Announces First Quarter 2004 Financial Results Webcast
Apr 02, 02
08:01 ET	Paradigm Genetics and BTR to Co-Market Capabilities To Bio-Processing Industry
Mar 04, 02
07:01 ET	Paradigm Genetics Announces Year End 2001 Financial Results, Revenue Increases 137 % Over 2000
Feb 26, 02
16:42 ET	Paradigm Genetics Announces Management Changes
08:04 ET	Paradigm Genetics and VDDI Pharmaceuticals Establish Collaboration In Novel Antibiotic Development Program
Feb 25, 02
08:07 ET	Paradigm Genetics and Duke University Medical Center Announce Collaborative Research Agreement in Metabolomics
Feb 07, 02
08:01 ET	Paradigm Genetics to Present at Wall Street Analyst Forum; Company Comfortable With Analysts' Consensus Estimates for 4Q01
Feb 06, 02
08:00 ET	Paradigm Genetics Delivers Novel Targets-Based Assays for Developing Herbicides to Bayer AG
Jan 07, 02
08:00 ET	Paradigm Genetics Names Top Systems Biology Expert To Its Board of Directors
07:45 ET	Paradigm Genetics CEO to Speak At The JPMorgan H&Q Healthcare Investment Conference
Nov 19, 01
08:31 ET	Paradigm Genetics And StemCo Biomedical Establish Collaboration To Determine Biochemical Profiles of Adult Human Stem Cells